NIOSHTIC-2 Publications Search
Adult blood lead epidemiology and surveillance - United States, third quarter, 1997.
Lofgren-JP; Schaller-K; Payne-S; Jung-BC; Gergely-R; Hawkes-A; Keyvan-Larijani-E; Rabin-R; Scoblic-M; Falken-M; Thistle-Elliott-L; Gerwel-B; Prophet-R; Stone-R; Randolph-S; Migliozzi-A; Rhoades-E; Sandoval-A; Gostin-J; Stoeckel-M; Gardner-Hillian-A; Schnitzer-P; Ball-W; Toof-L; Kaufman-J; Tierney-J; Klietz-T
MMWR 1998 Feb; 47(4):77-80
CDC's National Institute for Occupational Safety and Health (NIOSH) Adult Blood Lead Epidemiology and Surveillance program (ABLES) monitors laboratory-reported elevated blood lead levels (BLLs) among adults in the United States. During 1997, a total of 27 states reported surveillance data to ABLES. This report presents ABLES data for the first three quarters of 1997 and compares these data with the first three quarters of 1996. During July-September 1996 and 1997, reports from the same 27 states of BLLs greater than or equal to 25 ug/dL increased 6%, from 4879 to 5193, respectively (1). This quarterly increase followed an increase of 18%, from 5552 to 6564, during the first quarter and a decrease of 7%, from 6120 to 5709, during the second quarter of 1997 compared with the second quarter of 1996. These numbers reflect updated data from Alabama and Ohio for both 1997 and 1996 (2,3). The overall increase for the first three quarters of 1997 compared with the first three quarters of 1996 was 6% (Table-1); in comparison, the long-term trend had reflected a decrease during 1993-1996 (1,2,4) among adults in the United States (5). However, this 6% increase was not uniform; 14 states reported increases, nine states reported decreases, and four remained the same or did not report during both years (Figure-1).
Lead-absorption; Lead-compounds; Lead-dust; Blood-analysis; Blood-sampling; Central-nervous-system-disorders; Blood-disorders; Reproductive-system-disorders; Cardiovascular-system-disorders; Kidney-disorders; Environmental-exposure; Exposure-levels; Exposure-limits; Neurotoxic-effects; Surveillance-programs; Region-1; Region-10; Region-2; Region-3; Region-4; Region-5; Region-6; Region-7; Region-8; Region-9
Issue of Publication
Morbidity and Mortality Weekly Report
AL; CA; AZ; CT; IA; ME; MD; MA; MI; MN; NH; NJ
Page last reviewed: May 5, 2020
Content source: National Institute for Occupational Safety and Health Education and Information Division